Therapeutic inertia in diabetes management is the failure to initiate or intensify pharmacological treatment when a patient's glycated hemoglobin (HbA1c) goals are not me [...]

Farmworkers face significant disparities in healthcare access and outcomes, driven by factors such as rural residence, lack of insurance, language barriers, and undocumen [...]

Analyzing the literature regarding how adopting a Blue Zones-inspired lifestyle, diet, and exercise habits can improve the life longevity of middle-aged adults who have t [...]

This research encompasses the influence of the Blue Zones Project & Lifestyle as a means for blood glucose control & non-pharmacologic management for Type II Diab [...]

Type 1 diabetes is a medical condition characterized by pancreatic β-cell dysfunction and insulin depletion. Management of type 1 diabetes requires precise injections of [...]

Within the last five years, the prevalence of diabetes among inmates living in Oregon prisons has increased by 50%. [...]

The American Diabetes Association (ADA) established guidelines for HbA1c monitoring to reduce the risk of adverse events in patients with type 2 diabetes mellitus (T2DM). [...]

Recent studies have illustrated the benefits of implementing a protocol to manage diabetic ketoacidosis (DKA) with regards to intensive care unit (ICU) length of stay (LO [...]

Obesity is an ever-­‐growing concern in the United States and throughout much of the world. While our understanding [...]